Literature DB >> 2609940

Methotrexate-related multifocal axonopathy. Report of an autopsy case.

M Shibutani1, R Okeda, A Hori, H Schipper.   

Abstract

A case of multifocal axonopathy associated with intrathecal methotrexate (IT MTX) and radiation therapy is presented. A 33-year-old woman suffering from meningeal carcinomatosis of breast cancer origin had developed prominent multifocal axonal degeneration in the cerebral white matter after treatment with IT MTX therapy and cranial irradiation. The principal features of this axonal degeneration were segmental hydropic swellings, macrophage infiltration of swollen axons, and scattered spheroid formation associated with reactive astrocytosis. These features were similar to those observed in our previous experimental study using cats treated with IT MTX alone. This "multifocal axonopathy" without necrotizing lesions seems to be different from disseminated necrotizing leukoencephalopathy, and, therefore, may be another form of MTX-related leukoencephalopathy. IT MTX and cranial irradiation seem to have exerted synergistic effects in producing the "multifocal axonopathy" in this case.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2609940     DOI: 10.1007/bf00294671

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Proceedings: Parenchymatous degeneration of the central nervous system in childhood leukemia.

Authors:  B Hendin; D C DeVivo; R Torack; M E Lell; A H Ragab; T J Vietti
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

2.  Encephalopathy in acute leukaemia associated with methotrexate therapy.

Authors:  H E Kay; P J Knapton; J P O'Sullivan; D G Wells; R F Harris; E M Innes; J Stuart; F C Schwartz; E N Thompson
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

3.  Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.

Authors:  H Norrell; C B Wilson; D E Slagel; D B Clark
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

4.  Current status of intrathecal chemotherapy for human meningeal neoplasms.

Authors:  W A Bleyer
Journal:  Natl Cancer Inst Monogr       Date:  1977-12

5.  Methotrexate encephalopathy. A neuropathologic study.

Authors:  H M Liu; H S Maurer; S Vongsvivut; J J Conway
Journal:  Hum Pathol       Date:  1978-11       Impact factor: 3.466

6.  The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy.

Authors:  R A Price; P A Jamieson
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

7.  Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia.

Authors:  K Skullerud; K Halvorsen
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

8.  Experimental study on subacute neurotoxicity of methotrexate in cats.

Authors:  M Shibutani; R Okeda
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.

Authors:  L J Rubinstein; M M Herman; T F Long; J R Wilbur
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

10.  Pathology of delayed radiation brain damage: an experimental canine model.

Authors:  J K Tiller-Borcich; J R Fike; T L Phillips; R L Davis
Journal:  Radiat Res       Date:  1987-05       Impact factor: 2.841

View more
  2 in total

Review 1.  Atypical MRI findings in treatment-related leukoencephalopathy: case report.

Authors:  Y Ohmoto; K Kajiwara; S Kato; T Nisizaki; H Ito; S Tamura
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

2.  Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.

Authors:  Krzysztof Brzeziński
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.